X. Bai

Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study

Jun Wen, X. Bai, Xiao-meng Liu, 2022, Neuropsychiatric disease and treatment.

The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers

Meng Zhou, X. Bai, 2022, Frontiers in Oncology.

Efficacy of bevacizumab in the treatment of refractory brain edema of metastatic tumors from different sources

Yuan Zhang, Weilong Ding, X. Bai, 2021, Neurological research.

Insight on the hub gene associated signatures and potential therapeutic agents in epilepsy and glioma

Yiyao Cao, Wei Li, X. Bai, 2023, Brain Research Bulletin.

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study

Haifeng Zhao, M. Zeng, Jia Fan, 2022, Liver Cancer.